Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice

Inhibiting vascular endothelial growth factor (VEGF) is a therapeutic option in diabetic microangiopathy. However, VEGF is needed at physiological concentrations to maintain glomerular integrity; complete VEGF blockade has deleterious effects on glomerular structure and function. Anti-VEGF therapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Njau, Florence, Shushakova, Nelli, Schenk, Heiko, Wulfmeyer, Vera Christine, Bollin, Robin, Menne, Jan, Haller, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959593/
https://www.ncbi.nlm.nih.gov/pubmed/31935212
http://dx.doi.org/10.1371/journal.pone.0218494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959593/
https://www.ncbi.nlm.nih.gov/pubmed/31935212
http://dx.doi.org/10.1371/journal.pone.0218494

Ejemplares similares